JERUSALEM--(BUSINESS WIRE)--Mar. 12, 2018--
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) will host a
live audio webcast at the Cowen & Company 38th Annual
Healthcare Conference in Boston, MA.
|
|
|
|
|
When:
|
|
Tuesday, March 13, 2018 at 11:20 AM ET
|
|
|
|
|
|
Who:
|
|
Michael McClellan, EVP & Chief Financial Officer
|
|
|
|
Teva Pharmaceutical Industries Ltd.
|
|
|
|
|
|
Where:
|
|
http://wsw.com/webcast/cowen46/teva
|
|
|
|
|
|
How:
|
|
Live over the Internet – log on to the Web at the address above
and register for the event (approximately 10 minutes before). An
archive of the webcast will be available on Teva’s Website at http://ir.tevapharm.com.
|
|
|
|
|
About Teva
Teva Pharmaceutical Industries Limited (NYSE and TASE: TEVA) is a
leading global pharmaceutical company that delivers high-quality,
patient-centric healthcare solutions used by millions of patients every
day. Headquartered in Israel, Teva is the world’s largest generic
medicines producer, leveraging its portfolio of more than 1,800
molecules to produce a wide range of generic products in nearly every
therapeutic area. In specialty medicines, Teva has a world-leading
position in innovative treatments for disorders of the central nervous
system, including pain, as well as a strong portfolio of respiratory
products. Teva integrates its generics and specialty capabilities in its
global research and development division to create new ways of
addressing unmet patient needs by combining drug development
capabilities with devices, services and technologies. Teva's net
revenues in 2017 were $22.4 billion.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180312005616/en/
Source: Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
IR Contacts
United
States
Kevin C. Mannix, 215-591-8912
Ran Meir, 215-591-3033
or
Israel
Tomer
Amitai, 972 (3) 926 7656
or
PR Contacts
United
States
Kaelan Hollon, 202-412-7076
or
Israel
Yonatan
Beker, 972 (54) 888 5898